Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Gene Sequencing – to the Bedside

Reporter: Larry H Bernstein, MD, FCAP

Gene sequencing leaves the laboratory

Maturing technology speeds medical diagnoses.

Erika Check Hayden  19 February 2013

The steep fall in the cost of sequencing a genome has, for the moment, slowed. Yet researchers attending this year’s Advances in Genome Biology and Technology (AGBT) meeting in Marco Island, Florida, on 20–23 February are not complaining. At a cost as low as US$5,000–10,000 per human genome, sequencing has become cheap and reliable enough that researchers are not waiting for the next sequencing machine to perfect new applications in medicine.

http://www.nature.com/polopoly_fs/7.9051.1361287131!/image/Slide2.jpg_gen/derivatives/landscape_630/Slide2.jpg

Single-cell genomics is allowing fertility clinics to screen embryos for abnormalities more cheaply.

http://www.nature.com/news/gene-sequencing-leaves-the-laboratory-1.12454?WT.ec_id=NATURE-20130221

Human genome to genes (Photo credit: Wikipedia)

Related articles

• Genome sequencing of the Healthy (pharmaceuticalintelligence.com)
• 2013 Genomics: The Era Beyond the Sequencing Human Genome: Francis Collins, Craig Venter, Eric Lander, et al. (pharmaceuticalintelligence.com)
• Gene sequencing leaves the laboratory (nature.com)
• Real Time Genomics Announces Platform Launch, Expanding Commercial Operations (prweb.com)
• Solid-State Sequencer Debuts at Genome Conference (technologyreview.com)
• Research and Markets: DNA Sequencing – Technologies, Markets and Companies – 2013 (prweb.com)

00

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on LinkedIn (Opens in new window)
• Click to share on Facebook (Opens in new window)
• Click to print (Opens in new window)
• Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

Posted in International Global Work in Pharmaceutical, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical | Tagged AGBT, Biology, DNA, DNA sequencer, Florida, genetics, genome, Genome Biology, human genome, Marco Island Florida | 3 Comments

3 Responses

1. on March 4, 2013 at 4:58 AM | Reply How Genes Function | Pharmaceutical Intelligence

   I actually consider this amazing blog , “SAME SCIENTIFIC IMPACT: Scientific Publishing –
   Open Journals vs. Subscription-based « Pharmaceutical Intelligence”, very compelling plus the blog post ended up being a good read.
   Many thanks,Annette

   Loading...

   
   
2. on March 4, 2013 at 5:09 AM | Reply suraiyahaider

   I actually consider this amazing blog , “SAME SCIENTIFIC IMPACT: Scientific Publishing –
   Open Journals vs. Subscription-based « Pharmaceutical Intelligence”, very compelling plus the blog post ended up being a good read.
   Many thanks,Annette

   Loading...

   
   
3. on March 4, 2013 at 5:41 AM | Reply lindaedwards689

   I actually consider this amazing blog , “SAME SCIENTIFIC IMPACT: Scientific Publishing –
   Open Journals vs. Subscription-based « Pharmaceutical Intelligence”, very compelling plus the blog post ended up being a good read.
   Many thanks,Annette

   Loading...